BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9207351)

  • 1. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes.
    Smith IL; Cherrington JM; Jiles RE; Fuller MD; Freeman WR; Spector SA
    J Infect Dis; 1997 Jul; 176(1):69-77. PubMed ID: 9207351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
    James SH; Price NB; Hartline CB; Lanier ER; Prichard MN
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3321-5. PubMed ID: 23650158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cys607-->Tyr change in the UL97 phosphotransferase confers ganciclovir resistance to two human cytomegalovirus strains recovered from two immunocompromised patients.
    Baldanti F; Underwood MR; Talarico CL; Simoncini L; Sarasini A; Biron KK; Gerna G
    Antimicrob Agents Chemother; 1998 Feb; 42(2):444-6. PubMed ID: 9527804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of human cytomegalovirus to antiviral drugs.
    Erice A
    Clin Microbiol Rev; 1999 Apr; 12(2):286-97. PubMed ID: 10194460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase.
    James SH; Hartline CB; Harden EA; Driebe EM; Schupp JM; Engelthaler DM; Keim PS; Bowlin TL; Kern ER; Prichard MN
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4682-91. PubMed ID: 21788463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
    Chou S; Alain S; Cervera C; Chemaly RF; Kotton CN; Lundgren J; Papanicolaou GA; Pereira MR; Wu JJ; Murray RA; Buss NE; Fournier M
    J Infect Dis; 2024 Feb; 229(2):413-421. PubMed ID: 37506264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir.
    Bedard J; May S; Lis M; Tryphonas L; Drach J; Huffman J; Sidwell R; Chan L; Bowlin T; Rando R
    Antimicrob Agents Chemother; 1999 Mar; 43(3):557-67. PubMed ID: 10049267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients.
    Göhring K; Hamprecht K; Jahn G
    Comput Struct Biotechnol J; 2015; 13():153-9. PubMed ID: 25750703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus UL97 kinase alters the accumulation of CDK1.
    Gill RB; James SH; Prichard MN
    J Gen Virol; 2012 Aug; 93(Pt 8):1743-1755. PubMed ID: 22552942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir.
    Piret J; Boivin G
    Infect Dis Rep; 2024 Jan; 16(1):65-82. PubMed ID: 38247977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation.
    Heinz AT; Calkoen FGJ; Derbich A; Miltner L; Seitz C; Doering M; Braun C; Atar D; Schumm M; Heubach F; Arendt AM; Schulz A; Schuster FR; Meisel R; Strahm B; Finke J; Heineking B; Stetter S; Silling G; Stachel D; Gruhn B; Debatin KM; Foell J; Schulte JH; Woessmann W; Mauz-Körholz C; Tischer J; Feuchtinger T; Handgretinger R; Lang P
    Haematologica; 2023 Aug; 108(8):2080-2090. PubMed ID: 36794500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus retinitis in the highly active anti-retroviral therapy era.
    Ude IN; Yeh S; Shantha JG
    Ann Eye Sci; 2022 Mar; 7():. PubMed ID: 35498636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection.
    Landázuri N; Gorwood J; Terelius Y; Öberg F; Yaiw KC; Rahbar A; Söderberg-Nauclér C
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance.
    Chou S
    Antiviral Res; 2020 Apr; 176():104711. PubMed ID: 31940472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.
    López-Aladid R; Guiu A; Mosquera MM; López-Medrano F; Cofán F; Linares L; Torre-Cisneros J; Vidal E; Moreno A; Aguado JM; Cordero E; Martin-Gandul C; Carratalá J; Sabé N; Niubó J; Cervera C; Capón A; Cervilla A; Santos M; Bodro M; Muñoz P; Fariñas MC; Antón A; Aranzamendi M; Montejo M; Pérez-Romero P; Len O; Marcos MÁ
    PLoS One; 2019; 14(7):e0219701. PubMed ID: 31318908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, Assembly, and Modification of the Primary Human Cytomegalovirus Isolate Toledo by Yeast-Based Transformation-Associated Recombination.
    Vashee S; Stockwell TB; Alperovich N; Denisova EA; Gibson DG; Cady KC; Miller K; Kannan K; Malouli D; Crawford LB; Voorhies AA; Bruening E; Caposio P; Früh K
    mSphere; 2017; 2(5):. PubMed ID: 28989973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Ganciclovir Resistance in CMV-positive Renal Transplant Recipients and its Association with UL97 Gene Mutations.
    Aslani HR; Ziaie S; Salamzadeh J; Zaheri S; Samadian F; Mastoor-Tehrani S
    Iran J Pharm Res; 2017; 16(2):805-810. PubMed ID: 28979335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated Levels of Ganciclovir Resistance Conferred by Mutations at Codons 591 to 603 of the Cytomegalovirus UL97 Kinase Gene.
    Chou S; Ercolani RJ; Vanarsdall AL
    J Clin Microbiol; 2017 Jul; 55(7):2098-2104. PubMed ID: 28446569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection.
    Faure E; Galperine T; Cannesson O; Alain S; Gnemmi V; Goeminne C; Dewilde A; Béné J; Lasri M; Lessore de Sainte Foy C; Lionet A
    Medicine (Baltimore); 2016 Nov; 95(44):e5226. PubMed ID: 27858871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.
    El Chaer F; Shah DP; Chemaly RF
    Blood; 2016 Dec; 128(23):2624-2636. PubMed ID: 27760756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.